Nagendran, J <br/><br/>
Are users of sulphonylureas at the time of an acute coronary syndrome at risk of poorer outcomes?  [electronic resource] 

 -  Diabetes, obesity & metabolism  Nov 2013 
 - 1022-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1463-1326 
<br/><br/><label>Standard No.: </label>10.1111/dom.12126  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--complications<br/>Aged<br/>Aged, 80 and over<br/>Alberta--epidemiology<br/>Cohort Studies<br/>Diabetes Mellitus, Type 2--complications<br/>Diabetic Cardiomyopathies--diagnosis<br/>Female<br/>Heart Failure--etiology<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>KATP Channels--antagonists & inhibitors<br/>Logistic Models<br/>Male<br/>Medical Record Linkage<br/>Mortality<br/>Potassium Channel Blockers--adverse effects<br/>Prognosis<br/>Risk Factors<br/>Sulfonylurea Compounds--adverse effects